Kupwara, Oct 29: The Kupwara Chemists and Distributors Association on Thursday organised the first-ever pharma conference at Town Hall Kupwara, bringing together pharmaceutical professionals and officials to discuss drug regulation, public health and the pharmaceutical trade.
Tehsildar Kupwara Niyaz Ahmad attended the conference as the guest of honour and participated in discussions on measures to prevent the misuse of medicines and strengthen the monitoring of pharmaceutical outlets.
DySP Headquarters Mubashir Ahmad, speaking on the occasion, urged chemists to play an active role in curbing drug abuse and ensuring strict monitoring of medicine sales. He emphasised the importance of responsible dispensing practices and vigilance to prevent the misuse of medicines.
Assistant Drugs Controllers Dr Zaffar Ahmad Bhat and Dr Shabir Ahmad Bhat; Hina Hameed, Price Monitoring Resource Unit Project Coordinator, Jammu and Kashmir (PMRU); Reema Gazala, Ishrat Qadri, Field Investigator, PMRU Kashmir Division; and Drugs Control Officers (DCOs) Feroz Ahamad Bhat, Kupwara/Handwara, and Shabir Ahmad Pandit (Manufacturing), Kashmir Division, were also among the key participants.
On the occasion, DCO Shabir Ahmad Pandit (Manufacturing), Kashmir Division, presented official data and claimed that no duplicate medicines had been detected in Kashmir based on market samples collected over the past five years.
The conference focused on the Nasha Mukth Abhiyan, prescription and scheduled drugs (NRx), and price monitoring through the Price Monitoring and Resource Unit (PMRU). An interactive question-and-answer session was also held to address issues concerning pharmaceutical regulations and the responsibilities of chemists and distributors.
The programme aimed to promote the responsible sale and distribution of medicines, strengthen compliance with drug regulations and encourage collective efforts to curb substance abuse.
The association emphasised the importance of cooperation among chemists, distributors and drug regulatory authorities in ensuring the availability of safe and affordable medicines while protecting public health.
About The Author
